MAP2K1 and cancer: Similar to MEK1/2 inhibition, normal gastric organoids were more sensitive than cancer PDOs toward EGFR (AUCrel: 0.449 (normal) vs. 0.861 (PDOs)) and B‐RAF inhibition (AUCrel: 0.653 (normal) vs. 0.895 (PDOs)).